ELITE PHARMACEUTICALS INC /NV/ - 10-Q Filing

Elite Pharmaceuticals Inc. reports Q2 2027 financial results with significant revenue segmentation across Abbreviated New Drug Applications and licensing.

3 articles from 1 source · updated November 12, 2026, 22:24 UTC

Coverage

• ORAMED PHARMACEUTICALS INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:23 UTC
• ELITE PHARMACEUTICALS INC /NV/ - 8-K Filing SEC EDGAR · November 12, 2026, 22:20 UTC
• ELITE PHARMACEUTICALS INC /NV/ - 10-Q Filing SEC EDGAR · November 12, 2026, 21:05 UTC